Related Articles:

2-(2-Furanyl)-7-phenyl [1, 2, 4] triazolo [1, 5-c] pyrimidin-5-amine analogs as adenosine A 2A antagonists: The successful reduction of hERG activity. Part 2

[Matasi, Julius J.; Caldwell, John P.; Zhang, Hongtao; Fawzi, Ahmad; Higgins, Guy A.; Cohen-Williams, Mary E.; Varty, Geoffrey B.; Tulshian, Deen B. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 16 p. 3675 - 3678]

Highly potent aminopyridines as Syk kinase inhibitors

[Castillo, Marcos; Forns, Pilar; Erra, Montse; Mir, Marta; Lopez, Manel; Maldonado, Monica; Orellana, Adelina; Carreno, Cristina; Ramis, Isabel; Miralpeix, Montserrat; Vidal, Bernat Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 17 p. 5419 - 5423]

2-(2-Furanyl)-7-phenyl [1, 2, 4] triazolo [1, 5-c] pyrimidin-5-amine analogs as adenosine A 2A antagonists: The successful reduction of hERG activity. Part 2

[Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 16 p. 3675 - 3678]

2-(2-Furanyl)-7-phenyl [1, 2, 4] triazolo [1, 5-c] pyrimidin-5-amine analogs as adenosine A 2A antagonists: The successful reduction of hERG activity. Part 2

[Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 16 p. 3675 - 3678]

2-(2-Furanyl)-7-phenyl [1, 2, 4] triazolo [1, 5-c] pyrimidin-5-amine analogs as adenosine A 2A antagonists: The successful reduction of hERG activity. Part 2

[Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 16 p. 3675 - 3678]